Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Methylene dioxymethamphetamine

Allen RP, McCann UD, Ricaurte GA Persistent effects of +/- 3,4-methylene-dioxymethamphetamine (MDMA, ecstasy ) on human sleep. Sleep 16 560-564, 1993... [Pg.261]

Schmidt, C.J. Neurotoxicity of the psychedelic amphetamine, methylene dioxymethamphetamine. J Pharmacol Exp Ther 240 1-7, 1987a. [Pg.195]

Shankaran, M., Yamamoto, B.K., and Gudelsky, G.A., Mazindol attenuates the 3,4-methylene-dioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum, J. Neurochem. 72(6), 2516-2522, 1999. [Pg.137]

Sprouse, J.S., Bradberry, C.W., Roth, R.H., and Aghajanian, G.K., MDMA (3,4-methylene-dioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin, Eur. J. Pharmacol. 167(3), 375-383, 1989. [Pg.137]

Wang, X., Baumann, M.H., Xu, H., Morales, M., and Rothman, R.B., ( +/- )-3,4-Methylene-dioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane, J. Pharmacol. Exp. Ther. 314(3), 1002-1012, 2005. [Pg.140]

Bull, E.J., Hutson, P.H., and Fone, K.C., Reduced social interaction following 3,4-methylene-dioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity, Neuropharmacology 44(4), 439 148, 2003. [Pg.142]

Cameron R. Hekmatpanath, Dennis J. McKenna, and Stephen J. Peroutka. "Reserpine does not prevent 3,4-methylene-dioxymethamphetamine-induced neurotoxicity." Neuroscience Letters 104 (1989) 178-82. [Pg.177]

Fenfluramine Dextromethorphan Meperidine Methylene dioxymethamphetamine Meta-chlorophenylpiperazine (mCPP) Trazodone (mCPP) Selegiline Nefazodone Trazodone Pethidine Tramadol Mirtazapine TCA medications Venlafaxine SSRI agents... [Pg.278]

Parrott AC (2004). MDMA (3,4-methylene-dioxymethamphetamine) or ecstasy the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology, 50. 329-35... [Pg.166]

Smith, K. M., L. L. Larive, and F. Romanelli. Club Drugs Methylene-Dioxymethamphetamine, Flunitrazepam, Ketamine Hydrochloride and Gamma Hydroxybutyrate. American Journal of Health System Pharmacy 59 (2002) 1067-1076. [Pg.85]

Bhattachary S, Powell JH. Recreational use of 3,4-methylene-dioxymethamphetamine (MDMA) or ecstasy evidence for cognitive impairment. Psychol Med 2001 31(4) 647-58. [Pg.613]

Schmidt, C, ]. (1987). Neurotoxicity of the Psychedelic Amphetamine, Methylene-Dioxymethamphetamine, /. Phartnacci. Exp. Ther., 240 1-7. [Pg.277]

Johnson, M. Elayan, L Hanson, G.R. Foltz, R.L. Gibb, J.W. and Lim, H.K. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxy-methamphetamine, two metabolites of 3,4-methylene-dioxymethamphetamine, on central serotonergic and dopaminergic systems. J Pharmacol Exp Ther 261 447-453,... [Pg.143]

SLC6A4 (SERT) SERT plays a role in the reuptake and clearance of serotonin in the brain. Like the other SLC6A family members, SERT transports its substrates in a Na+-dependent fashion and is dependent on CL and possibly on the countertransport of K+. Substrates of SERT include serotonin (5-HT), various tryptamine derivatives, and neurotoxins such as 3,4-methylene-dioxymethamphetamine (MDMA ecstasy) and fenfluramine. SERT is the specific target of the selective serotonin reuptake inhibitors (e.g., fluoxetine and paroxetine) and one of several targets of tricyclic antidepressants e.g., amitriptyline). Genetic variants of SERT have been associated with an array of behavioral and neurological disorders. The precise mechanism by which a reduced activity of SERT, caused by either a genetic variant or an antidepressant, ultimately affects mood and behavior is not known. [Pg.42]

Schedule I (examples heroin, methylene dioxymethamphetamine, lysergic acid diethylamide, mescaline, and all salts and isomers thereof) ... [Pg.1144]

Ahmadi et al. used MlPs as a selective sorbent for extraction of 3,4-methylene dioxymethamphetamine [MDMA], a strong central nervous system stimulant from plasma samples [Ahmadi et al., 2011]. Ab initio calculations were used to measure AE of template-monomer complexes on Gaussian 03 software utilizing B3LYP/6-31-G[d,p] basis set. The MDMA interacted more strongly with methacrylic acid [MAA] in comparison to other functional monomers and the MAA-based MlPs, was used for the cleanup of MDMA from human plasma with the sufficient accuracy and precision. [Pg.627]

See other pages where Methylene dioxymethamphetamine is mentioned: [Pg.264]    [Pg.88]    [Pg.137]    [Pg.137]    [Pg.139]    [Pg.141]    [Pg.917]    [Pg.41]    [Pg.259]    [Pg.142]    [Pg.59]    [Pg.540]    [Pg.290]   


SEARCH



© 2024 chempedia.info